By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Crown Bioscience, Inc. 

4008 Burton Drive

Santa Clara  California  95054  U.S.A.
Phone: 617-818-2285 Fax: 408-986-0019

Crown Bioscience, Inc. is a premium biology CRO, providing discovery and early development solutions for global biotech and pharmaceutical companies. It is headquartered in the Silicon Valley, with wholly owned research centers in Beijing, China and Indianapolis. Crown Bioscience is the leader in providing high-quality and cost-effective services in preclinical oncology. Our services include target protein expression, purification and crystallization, in vitro/in vivo pharmacology, non-GLP toxicology, PK/PD, and translational research with patient-derived cell lines and animal models.

For more information, please visit our web site at

Key Statistics

Ownership: Private

Web Site: Crown Bioscience, Inc.



Company News
Crown Bioscience, Inc. Brings Top Scientists Together To Discuss Best Approaches To Advance Translational Oncology 9/30/2015 10:45:22 AM
Crown Bioscience, Inc. Expands Its Presence In France With Severine Marrony, Ph.D. 9/24/2015 11:16:27 AM
Crown Bioscience, Inc. Strengthen Position In Europe With Appointment Of New Business Development Manager 3/12/2015 8:49:18 AM
Suneva Medical Selects Crown Bioscience, Inc. To Co-Promote ReFissa 3/2/2015 9:23:52 AM
Crown Bioscience, Inc. Buys PDX Unit From Molecular Response (MRL) 2/18/2015 11:57:59 AM
Molecular Response (MRL) Announces Sale of Business Unit To Crown Bioscience, Inc. 2/12/2015 1:07:54 PM
Crown Bioscience, Inc. Announces A Key Expansion Of Its Partnership With The National Resource Center For Mutant Mice (NRCMM) On Developing Novel Immuno-Oncology Mouse Models 2/4/2015 8:57:31 AM
Crown Bioscience, Inc. Strengthens Pre-Clinical Leadership Team With Senior Appointment 1/28/2015 9:22:20 AM
Crown Bioscience, Inc. Announces First European Symposium On Translational Oncology And The Use Of Patient-Derived Xenograft Models For Oncology Drug Discovery And Human Surrogate Trials 1/14/2015 11:16:45 AM
Crown Bioscience, Inc. Expands Operations And Re-Brands UK Site 1/8/2015 11:01:38 AM